Yaoyao Jing

Changhongjie, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Treatment prioritization of chemotherapy-anchored regimens after EGFR-TKI failure in EGFR-mutant NSCLC: a systematic review, pairwise meta-analysis and Bayesian network meta-analysis with probabilistic multi-criteria decision analysis.

Treatment prioritization of chemotherapy-anchored regimens after EGFR-TKI failure in EGFR-mutant NSCLC: a systematic review, pairwise meta-analysis and Bayesian network meta-analysis with probabilistic multi-criteria decision analysis.

Journal: Frontiers in immunology

Published: April 24, 2026

Ferroptotic resistance involved in PTEN-loss prostate cancer progression.

Ferroptotic resistance involved in PTEN-loss prostate cancer progression.

Journal: Discover oncology

Published: June 05, 2025

p53/PD-L1 co-expression predicts poor prognosis in diffuse large B-cell lymphoma.

p53/PD-L1 co-expression predicts poor prognosis in diffuse large B-cell lymphoma.

Journal: Discover oncology

Published: March 20, 2025

Clinical characteristics and survival of breast cancer patients with extramammary malignancies in a single Asian center over the past 23 years.

Clinical characteristics and survival of breast cancer patients with extramammary malignancies in a single Asian center over the past 23 years.

Journal: Discover oncology

Published: December 25, 2024

Follicular lymphoma grade 3A: aggressiveness and curability in an Asian cohort of 781 patients.

Follicular lymphoma grade 3A: aggressiveness and curability in an Asian cohort of 781 patients.

Journal: Annals of hematology

Published: November 11, 2024

FDG-PET/CT Provides Clues on Bone Marrow Involvement in Follicular Lymphoma and Carries Important Prognostic Information.

FDG-PET/CT Provides Clues on Bone Marrow Involvement in Follicular Lymphoma and Carries Important Prognostic Information.

Journal: Journal of Cancer

Published: June 27, 2023

Clinical characteristics and survival of second primary breast carcinoma with extramammary malignancies.

Clinical characteristics and survival of second primary breast carcinoma with extramammary malignancies.

Journal: Frontiers in oncology

Published: February 07, 2023

Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker.

Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker.

Journal: Frontiers in genetics

Published: August 30, 2022

p53 Deletion promotes myeloma cells invasion by upregulating miR19a/CXCR5.

p53 Deletion promotes myeloma cells invasion by upregulating miR19a/CXCR5.

Journal: Leukemia research

Published: February 25, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026